Markets

OpenText launched its Content Cloud solutions for Guidewire, aiming to accelerate insurers’ cloud migration and provide AI-driven access to policy and claims data. Integrated with Guidewire’s PolicyCenter, ClaimCenter, and BillingCenter, these solutions embed content and AI into core workflows, reducing information search time and improving efficiency. Insurers are using OpenText to centralize content, streamline compliance, and unlock AI-driven insights. The solutions are available on the Guidewire Marketplace.

Auxly Cannabis Group Inc. has fully repaid its $5 million inventory loan to GrassHopper Capital Inc. using existing cash reserves. This move is projected to save approximately $900,000 in annual interest expenses and reflects a strategic focus on financial discipline. The repayment allows for greater capital allocation flexibility, potentially freeing up resources for future organic growth investments. CEO Hugo Alves cited growing profitability and a stable cost base driving free cash flow as reasons for prioritizing debt reduction.

FireFox Gold (FFOXF) reported encouraging results from initial drilling at its Mustajärvi Gold Project in Finland. Hole 25MJ001 yielded significant gold intercepts, including 9.55 meters at 9.35 g/t Au. Additional holes showed high-grade, narrow intercepts, with Hole 25MJ003 hitting 0.9 meters at 104 g/t Au. The company validated its FLEM targeting methodology and is expanding surveys. A ~10,000-meter drill program through spring 2026 is underway; the first phase comprised 3,985.3 meters. Reported intervals are core width; true width is unknown.

Questcorp Mining Inc. (QQQ:CSE) closed the initial tranche of a non-brokered private placement, raising $2,100,050. The company issued 14,000,334 units at $0.15, each including a share and a half warrant exercisable at $0.20. Funds will advance exploration at La Union (Mexico) and North Island (Canada). A $2M portion is subject to a sharing agreement with Sorbie Bornholm LP. Questcorp anticipates a final tranche, aiming for total proceeds of $3.5M. Units from the first tranche are free trading.

HIVE Digital Technologies reports significant expansion in Bitcoin mining, exceeding 22 EH/s, a 267% year-to-date increase, and producing 9.5 BTC daily with high fleet efficiency. Strategically repurposing infrastructure, HIVE is converting a data center into a Tier-3 HPC facility housing 2,000 NVIDIA GPUs for AI cloud computing, aiming for 6,000 GPUs by 2026. Ambitious targets include reaching 25 EH/s by late 2025 and 35 EH/s in 2026, underpinned by a commitment to renewable energy sources. Potential risks include dependence on ASIC miner deployment and validation of Boden conversion timeline.

CSL’s Broadmeadows facility in Australia has won the ISPE’s 2025 Facility of the Year Award as Overall Winner. The plasma fractionation plant is recognized for its Pharma 4.0 integration, pioneering hybrid manufacturing platform, and sustainable design. Advanced automation, real-time monitoring, robotics, and a digital twin infrastructure contribute to increased plasma processing capacity and efficiency. The facility’s sustainable features include reusable filters and energy-efficient systems. The award acknowledges CSL’s commitment to innovation, operational excellence, and environmental responsibility.

Genenta Science (GNTA) announced a $15.0 million registered direct offering on October 27, 2025, involving 4,285,715 American Depositary Shares (ADSs) sold to institutional investors at $3.50 per ADS. Maxim Group LLC and Rodman & Renshaw LLC acted as placement agents. The offering is expected to close around October 28, 2025, with net proceeds intended for working capital and general corporate purposes, potentially advancing clinical trials of its Temferon technology. The offering is being made under a shelf registration statement previously filed with the SEC.

POET Technologies (NASDAQ: POET) secured approximately $150 million in gross proceeds through an oversubscribed registered direct offering of common shares, attracting new institutional investors. Closing is expected around October 28, 2025, pending standard conditions. POET intends to use the net proceeds for acquisitions, R&D, and operational expansion. Pro-forma cash is expected to exceed $300 million post-closing. While the offering provides financial runway, the share issuance may cause dilution.

Castle Biosciences’ TissueCypher Barrett’s Esophagus test demonstrates risk insights beyond pathology, influencing clinical management, according to new data presented at ACG 2025. Research by Horvath et al. on TissueCypher received a Presidential Poster Award. Case studies showed TissueCypher identified patients at high risk for progression to esophageal cancer, prompting earlier interventions. In a rural study, the test influenced clinical management in 93% of cases, safely extending surveillance intervals for low-risk patients while ensuring timely intervention for higher-risk individuals.

Novartis intends to acquire Avidity Biosciences for $12 billion, a 46% premium, focusing on Avidity’s neuroscience pipeline and Antibody Oligonucleotide Conjugates (AOCs™) platform enabling targeted RNA delivery. The deal hinges on spinning off Avidity’s cardiology programs into “SpinCo,” capitalized with $270 million. Novartis gains access to late-stage clinical programs for Duchenne muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy, aligning with its neuroscience portfolio. SpinCo will advance cardiology-focused AOC programs and existing collaborations. The acquisition awaits regulatory approval.